SG Americas Securities’s Medtronic MDT Stock Holding History

SG Americas Securities’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-252,200	Closed	-$125K	–	3505
2025 Q4	$125K	Buy	252,200 +225,000	+827%	+$21.9M	﹤0.01%	3130
2025 Q3	$128K	Hold	27,200	–	–	﹤0.01%	2974
2025 Q2	$63K	Buy	27,200 +14,500	+114%	+$1.23M	﹤0.01%	2733
2025 Q1	$52K	Buy	+12,700	New	+$1.14M	﹤0.01%	3238
2024 Q3	–	Sell	-500,000	Closed	-$428K	–	3526
2024 Q2	$428K	Buy	+500,000	New	+$41M	﹤0.01%	1752
2021 Q4	–	Sell	-63,000	Closed	-$44K	–	3639
2021 Q3	$44K	Buy	63,000 +25,800	+69%	+$3.34M	﹤0.01%	3744
2021 Q2	$2K	Buy	+37,200	New	+$4.67M	﹤0.01%	2809
2021 Q1	–	Sell	-94,200	Closed	-$81K	–	3437
2020 Q4	$81K	Buy	94,200 +10,000	+12%	+$1.1M	﹤0.01%	3090
2020 Q3	$101K	Buy	84,200 +40,000	+90%	+$4.02M	﹤0.01%	2456
2020 Q2	$20K	Buy	44,200 +25,000	+130%	+$2.4M	﹤0.01%	3600
2020 Q1	$51K	Sell	19,200 -227,000	-92%	-$24.1M	﹤0.01%	3173
2019 Q4	$823K	Sell	246,200 -7,000	-3%	-$768K	0.01%	1410
2019 Q3	$1.2M	Buy	253,200 +146,100	+136%	+$15.2M	0.01%	1292
2019 Q2	$364K	Buy	107,100 +43,300	+68%	+$3.95M	﹤0.01%	2086
2019 Q1	$205K	Sell	63,800 -49,900	-44%	-$4.47M	﹤0.01%	2552
2018 Q4	$464K	Buy	113,700 +7,500	+7%	+$701K	﹤0.01%	1916
2018 Q3	$1.15M	Buy	106,200 +60,000	+130%	+$5.55M	0.01%	1583
2018 Q2	$158K	Sell	46,200 -16,600	-26%	-$1.39M	﹤0.01%	2763
2018 Q1	$143K	Sell	62,800 -26,100	-29%	-$2.15M	﹤0.01%	2678
2017 Q4	$178K	Buy	88,900 +31,200	+54%	+$2.5M	﹤0.01%	2523
2017 Q3	$37K	Buy	57,700 +18,200	+46%	+$1.51M	﹤0.01%	3358
2017 Q2	$153K	Buy	39,500 +21,300	+117%	+$1.8M	﹤0.01%	2615
2017 Q1	$56K	Sell	18,200 -33,500	-65%	-$2.62M	﹤0.01%	3096
2016 Q4	$31K	Hold	51,700	–	–	﹤0.01%	2960
2016 Q3	$267K	Sell	51,700 -126,800	-71%	-$11M	﹤0.01%	2246
2016 Q2	$1.19M	Buy	178,500 +126,800	+245%	+$10.3M	0.01%	1187
2016 Q1	$117K	Sell	51,700 -145,800	-74%	-$11M	﹤0.01%	2531
2015 Q4	$60K	Buy	+197,500	New	+$14.9M	﹤0.01%	2449
2015 Q3	–	Sell	-151,300	Closed	-$184K	–	2460
2015 Q2	$184K	Buy	151,300 +93,000	+160%	+$7.11M	﹤0.01%	2018
2015 Q1	$207K	Buy	+58,300	New	+$4.42M	﹤0.01%	1863
2014 Q4	–	Sell	-45,400	Closed	-$348K	–	3272
2014 Q3	$348K	Sell	45,400 -156,000	-77%	-$9.92M	﹤0.01%	1665
2014 Q2	$847K	Buy	201,400 +92,800	+85%	+$5.64M	﹤0.01%	1440
2014 Q1	$407K	Sell	108,600 -9,000	-8%	-$524K	﹤0.01%	1592
2013 Q4	$1.56M	Sell	117,600 -133,600	-53%	-$7.58M	0.01%	1026
2013 Q3	$1.34M	Sell	251,200 -818,300	-77%	-$44M	0.01%	1135
2013 Q2	$1.35M	Buy	+1,069,500	New	+$52.9M	0.01%	902

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's MDT Position: Q1 2026 in Review

SG Americas Securities sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,510,712 shares — an estimated $241M sold.

SG Americas Securities first reported a position in MDT in Q2 2013 and held it in 51 quarters. The position peaked at $241M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

SG Americas Securities reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
SG Americas Securities sold 2,510,712 Medtronic shares in Q1 2026, an estimated $241M.
SG Americas Securities first reported a position in Medtronic in Q2 2013 and held it in 51 quarters.
SG Americas Securities's Medtronic position peaked at $241M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.